NORDIC
NORDIC, officially known as Nordic Pharma, is a prominent player in the pharmaceutical industry, headquartered in France. Established in 2011, the company has rapidly expanded its operations across Europe, focusing on key markets in the UK, Germany, and Scandinavia. NORDIC is dedicated to providing high-quality, innovative medicines, particularly in the fields of oncology, pain management, and rare diseases. With a commitment to patient-centric solutions, NORDIC distinguishes itself through its robust portfolio of specialty pharmaceuticals and a strong emphasis on research and development. The company has achieved significant milestones, including strategic partnerships and the successful launch of several unique therapies. NORDIC's reputation for excellence and reliability positions it as a trusted name in the pharmaceutical sector, making substantial contributions to healthcare advancements across its operational regions.
DitchCarbon Score
How does NORDIC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
NORDIC's score of 25 is higher than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
NORDIC's reported carbon emissions
In 2022, NORDIC reported total carbon emissions of approximately 1,390,728,000 kg CO2e. This figure includes 596,641,000 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources, and 148,407,000 kg CO2e from Scope 2 emissions, representing indirect emissions from the generation of purchased electricity. Additionally, Scope 3 emissions, which encompass all other indirect emissions, amounted to about 645,681,000 kg CO2e. Comparatively, in 2021, NORDIC's total emissions were about 856,852,000 kg CO2e, with Scope 1 emissions at 434,453,000 kg CO2e, Scope 2 emissions at 14,726,000 kg CO2e, and Scope 3 emissions reaching approximately 407,672,000 kg CO2e. This indicates a significant increase in emissions from 2021 to 2022. Despite the lack of specific reduction targets or initiatives disclosed, NORDIC's commitment to addressing climate change is evident through its comprehensive emissions reporting across all three scopes. The company continues to navigate the complexities of carbon management in a rapidly evolving industry landscape.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2021 | 2022 | |
|---|---|---|
| Scope 1 | 434,453,000 | 000,000,000 |
| Scope 2 | 14,726,000 | 000,000,000 |
| Scope 3 | 407,672,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
NORDIC is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
